These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34431461)
1. Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges. Chaurawal N; Misra C; Raza K Curr Drug Targets; 2022; 23(6):544-558. PubMed ID: 34431461 [TBL] [Abstract][Full Text] [Related]
2. Promises of Lipid-based Drug Delivery Systems in the Management of Breast Cancer. Thotakura N; Gupta MM; Rajawat JS; Raza K Curr Pharm Des; 2021; 27(45):4568-4577. PubMed ID: 34323182 [TBL] [Abstract][Full Text] [Related]
3. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review. Kothapalli P; Vasanthan M Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118 [TBL] [Abstract][Full Text] [Related]
4. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer. Mukherjee D; Raikwar S AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013 [TBL] [Abstract][Full Text] [Related]
5. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications. Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769 [TBL] [Abstract][Full Text] [Related]
6. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs. Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270 [TBL] [Abstract][Full Text] [Related]
7. Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches. Aslam M; Javed MN; Deeb HH; Nicola MK; Mirza MA; Alam MS; Akhtar MH; Waziri A CNS Neurol Disord Drug Targets; 2022; 21(10):952-965. PubMed ID: 34967302 [TBL] [Abstract][Full Text] [Related]
8. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins. Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658 [TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy. Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015 [TBL] [Abstract][Full Text] [Related]
10. Novel taxanes in development: Hopes or hypes? Lei L; Wang XJ; Tang SC Crit Rev Oncol Hematol; 2022 Aug; 176():103727. PubMed ID: 35644326 [TBL] [Abstract][Full Text] [Related]
11. Current approaches in lipid-based nanocarriers for oral drug delivery. Plaza-Oliver M; Santander-Ortega MJ; Lozano MV Drug Deliv Transl Res; 2021 Apr; 11(2):471-497. PubMed ID: 33528830 [TBL] [Abstract][Full Text] [Related]
12. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives. Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134 [TBL] [Abstract][Full Text] [Related]
13. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors. Okur NÜ; Siafaka PI; Gökçe EH Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006 [TBL] [Abstract][Full Text] [Related]
14. Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin. Musika J; Chudapongse N Planta Med; 2020 Mar; 86(5):364-372. PubMed ID: 32005042 [TBL] [Abstract][Full Text] [Related]